Severe thrombocytopenia, thrombosis and anti-PF4 antibody after Pfizer-BioNTech COVID-19 mRNA vaccine booster-Is it vaccine-induced Immune thrombotic thrombocytopenia? by Ling, Victor W. T., Fan, Eugene Bingwen, Lau, Soon Lee, Lee, Xiu Hue, Tan, Chuen Wen, Lee, Shir Ying

“…Herein, we report a case of possible VITT after the Pfizer-BioNTech mRNA vaccine booster, who presented with extensive lower limb deep vein thrombosis, severe thrombocytopenia, markedly elevated D-dimer and positive anti-PF4 antibody occurring 2 weeks post-vaccination, concurrent with a lupus anticoagulant. …”
Get full text

Prevalence of side-effects associated with the booster dose of Pfizer-BioNTech (BNT162b2) of COVID-19 Vaccine among vaccinated adults in the Eastern province of Saudi Arabia by Jenan Ahmed Al-Matouq, Mohammad Daud Ali, Samiah Mohammad Al-Somali, Ayaz Ahmad, Nuzhat Banu, Munfis Patel

“…Conclusion: According to this study, the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine was safe when given to Saudi Arabian adults. …”
Get full text

The SARS-CoV-2 spike residues 616/644 and 1138/1169 delineate two antibody epitopes in COVID-19 mRNA COMINARTY vaccine (Pfizer/BioNTech) by Jessica Andries, Wildriss Viranaicken, Colette Cordonin, Charline Herrscher, Cynthia Planesse, Bénédicte Roquebert, Marie Lagrange-Xelot, Chaker El-Kalamouni, Olivier Meilhac, Patrick Mavingui, David Couret, Gilles Gadea, Philippe Despres

“…This raises the question on the role of the B-cell epitope peptide containing the SARS-CoV-2 spike residues 1138/1169 in protective efficacy of the Pfizer-BioNTech COVID-19 vaccine comirnaty.…”
Get full text

Safety of COVID-19 Pfizer-BioNtech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis by Patrick D. M. C. Katoto, Amanda S. Brand, Liliane N. Byamungu, Jacques L. Tamuzi, Tamirirashe C. Mahwire, Marcel K. Kitenge, Charles S. Wiysonge, Glenda Gray

Get full text

Immunogenicity and reactogenicity of COVID-19 Pfizer-BioNTech (Bnt162b2) mRNA vaccination in immunocompromised adolescents and young adults: a systematic review and meta-analyses by Patrick DMC Katoto, Mireille AM Kakubu, Jacques L. Tamuzi, Amanda S. Brand, Adaeze Ayuk, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray

Get full text

BNT162b2 (Pfizer/BioNTech) COVID-19 Vaccination Was Not Associated with the Progression of Activity of the Exudative Form of Age-Related Macular Degeneration during Anti-VEGF Therapy by Bernadetta Płatkowska-Adamska, Agnieszka Bociek, Joanna Krupińska, Magdalena Kal, Michał Biskup, Dorota Zarębska-Michaluk, Dominik Odrobina

“…Background: Evaluation of the activity of the exudative form of age-related macular degeneration (AMD) during anti-vascular endothelial growth factor (anti-VEGF) therapy before and after administration of BNT162b2 (Pfizer/BioNTech) vaccination. Methods: The optical coherence tomography and best corrected visual acuity (BCVA) records of the two previous visits before the first dose of BNT162b2 (first pre-vaccination visit marked as “V-1”, the previous pre-vaccination “V-2”), and two subsequent visits after the second dose of vaccination (first visit after the second dose marked as “V1”, second visit after the second dose marked as “V2”) were collected for 63 eyes of 59 patients. …”
Get full text

Incidencia y factores asociados con las reacciones adversas tras la primera dosis de la vacuna Pfizer-BioNTech en trabajadores de la salud by José E. López-Contreras, Patricia Paredes-Casillas, Jaime Morales-Romero, Francisco E. Castillo-Vélez, Juan C. Lona-Reyes, Martín Bedolla-Barajas

“…Objetivo: Determinar la incidencia de reacciones adversas (RA) tras la primera dosis de la vacuna Pfizer-BioNTech e identificar algunos factores asociados con ellas. …”
Get full text

Effectiveness of COVID-19 Pfizer-BioNTech (BNT162b2) mRNA vaccination in adolescents aged 12–17 years: A systematic review and meta-analysis by Patrick DMC. Katoto, Jacques L. Tamuzi, Amanda S. Brand, Diana M. Marangu, Liliane N. Byamungu, Charles S. Wiysonge, Glenda Gray

Get full text

Minimal Change Disease After First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Review of Minimal Change Disease Related to COVID-19 Vaccine by Jessica Hanna, Alistair Ingram, Tiffany Shao

“…Novel findings: De novo minimal change disease with acute tubular injury is a kidney manifestation following the administration of Pfizer-BioNTech COVID-19 vaccine. Minimal change disease is potentially a rare complication of Pfizer-BioNTech COVID-19 vaccine.…”
Get full text

Evaluation of Post-Vaccination Symptoms of Two Common COVID-19 Vaccines Used in Abha, Aseer Region, Kingdom of Saudi Arabia by Adam M, Gameraddin M, Alelyani M, Alshahrani MY, Gareeballah A, Ahmad I, Azzawi A, Komit B, Musa A

Subjects: Get full text

Adverse Events of COVID-19 Vaccination among the Saudi Population: A Systematic Review and Meta-Analysis by Abdulaziz Alhossan, Amjad Khalid Alsaran, Afnan Hussain Almahmudi, Ziad Saad Aljohani, Mohammed Rajeh Albishi, Ahoud Khashman Almutairi

Subjects: Get full text

Impact of previous infection and body mass index on interferon-gamma and immunoglobulin G level generated against three types of vaccines available in Iraq by Rawaq Taleb Hassan, Suhad Hadi Mohammed

Subjects: Get full text

COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy by Firdevs Ezgi Uçan Tokuç, Fatma Genç, Yasemin Biçer Gömceli

Subjects: Get full text

Psychosocial rehabilitation:a model by Rajah Rehabilitation Centre by Nechiyilthody Pfizer, M A Kavitha

Get full text

The usability of testing skin reaction applying skin prick tests with Comirnaty (Pfizer, USA) vaccine in detecting the risk of developing post-vaccination immediate hypersensitivity response (anaphylaxis) after administration of this vaccine by Ewelina Gulas, Andrzej Bant, Jerzy Kruszewski, Barbara Betiuk, Marek Niedoszytko, Andrzej Chciałowski

Get full text

The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine by Eman Farid, Eman Farid, Eman Farid, Juber Herrera-Uribe, Nigel J. Stevenson, Nigel J. Stevenson

Subjects: Get full text

Histopathologically TMA-like distribution of multiple organ thromboses following the initial dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech): an autopsy case report by Ryo Kaimori, Haruto Nishida, Tomohisa Uchida, Mari Tamura, Kohji Kuroki, Kumi Murata, Kinta Hatakeyama, Yoshihiko Ikeda, Kisaki Amemiya, Akira Nishizono, Tsutomu Daa, Shinjiro Mori

“…Here, we report an autopsy case of multiple thromboses after receiving the first dose of the BNT162b2 mRNA vaccine (Comirnaty, Pfizer/BioNTech) in an elderly woman. Case presentation A 72-year-old woman with a history of diffuse large B-cell lymphoma in the stomach and hyperthyroidism received the first dose of the BNT162b2 mRNA vaccine and died 2 days later. …”
Get full text

Clinical and Serological Follow-Up of 216 Patients with Hematological Malignancies after Vaccination with Pfizer-BioNT162b2 mRNA COVID-19 in a Real-World Study by Jean-François Rossi, Emmanuel Bonnet, Christel Castelli, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, Céleste David, Jérôme Dinet, Roland Sicard, Jean-Pierre Daures, Marion Bonifacy, Lysiane Mousset, Emmanuel Goffart

“…The aim of this real-world study was to analyze it after Pfizer-BioNT162b2 mRNA vaccination in 216 patients followed up for 1 year. …”
Get full text

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile by Diego A. Díaz-Dinamarca, Pablo Díaz, Gisselle Barra, Rodrigo Puentes, Loredana Arata, Jonnathan Grossolli, Boris Riveros-Rodriguez, Luis Ardiles, Julio Santelises, Julio Santelises, Valeria Vasquez-Saez, Daniel F. Escobar, Daniel Soto, Cecilia Canales, Janepsy Díaz, Liliana Lamperti, Daniela Castillo, Mychel Urra, Felipe Zuñiga, Valeska Ormazabal, Estefanía Nova-Lamperti, Rosana Benítez, Alejandra Rivera, Claudia P. Cortes, Claudia P. Cortes, Claudia P. Cortes, María Teresa Valenzuela, Heriberto E. García-Escorza, Abel E. Vasquez, Abel E. Vasquez, Abel E. Vasquez

Subjects: Get full text

Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/WyethTM) by Mauro César da Silva, Neila Caroline Henrique da Silva, Ana Laura Carneiro Gomes Ferreira, Fernanda Carneiro Gomes Ferreira, Maria Inês Bezerra de Melo, Letícia Micherlyne Xavier da Silva, Camila Rodrigues de Melo Barbosa, Jurandy Júnior Ferraz de Magalhães, George Tadeu Nunes Diniz, Ariani Impieri Souza, Norma Lucena-Silva

Get full text